Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PHENTERMINE HYDROCHLORIDE
- Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
- A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subjects
- Long-term Effectiveness of the Antiobesity Medication Phentermine
- Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
- Obesity and Uric Acid Stones Study
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Medications After Adolescent Bariatric Surgery
- Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
- Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
- Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity
- Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
- SMART Use of Medication for the Treatment of Adolescent Severe Obesity
- Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
- Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment
- Orlistat/Phentermine Versus Placebo/Phentermine
- Individualized Obesity Pharmacotherapy
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Lifestyle Modification and Liraglutide
- Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- A Study to Evaluate Abuse Potential of Istradefylline
- FDA Approved Medication to Reduce Binge Eating and/or Purging
- Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
- Topiramate-Phentermine Combinations for Cocaine Dependence
- Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects
- A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight
- Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
- A Toolbox Approach to Obesity Treatment in Primary Care
- Studying the Effects of Phentermine on Eating Behavior
- Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
- The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
- Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
- Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214
- Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal
- A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
- Phentermine/Gastric Band Weight Loss Study
- A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment
- Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults
- A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
- Cardiovascular System in Obesity: Effect of Treatment
Clinical trials list
click for details